drugset / Trial / NCT01013779

Merkel Positron Emission Tomography (PET) Protocol

NCT01013779 ↗

Phase 2 Completed 43 enrolled Trans Tasman Radiation Oncology Group
NaSingle-groupOpen-labelTreatment

Summary

A Phase II Study designed to evaluate the efficacy of Chemo-Radiotherapy in achieving loco-regional control in patients with Merkel Cell Carcinoma (MCC) of the skin. Patients will undergo PET scans to assist in staging and planning the patient's treatment as well as assessing response at the conclusion of treatment.

Timeline

Start
2009-12
Primary completion
2021-06
Completion
2021-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 2 unknown Intravenous
Subject Carboplatin Small molecule 4.5 unknown Intravenous
Subject Etoposide Small molecule 80 mg/m2 Intravenous